Spotlight and Analysguiden in new collaboration
Spotlight and Aktiespararna’s service Analysguiden has started a new collaboration on analyst coverage of the companies within Spotlight's new segment, Next. Next is a segment that will be launched shortly for companies ready for the next step
Spotlight has since the start worked to create the best possible conditions for growth companies. It means access to both expansion capital as well as the advantages of the stock exchange in order to continue to develop its business.
We work hard to simplify the everyday life as a listed company by being available to the companies and making them more visible to investors. We believe that the easier and safer it is to be listed, the easier and safer it is to become a shareowner in the companies.
“Collaboration with a serious and knowledgeable actor who, just like Spotlight, strives for a healthy equity environment and encourages investments in open and honest companies, is a natural choice for us.
We have ambitious goals: to become the marketplace in the Nordic where it is easiest, safest and most visible to be listed. It is a high goal, of course, but we are well on our way”, says Peter Gönczi, CEO,Spotlight
"Spotlight's development is impressive and this effort is fully in line with the Aktiespararna’s goal, to make investments in listed companies as simple and secure as possible," says Channa Hirsch, Sales Manager at Aktiespararna.
“Aktiesparana takes a big step upwards through this collaboration. It is very stimulating to be able to be a part of this innovative journey", says Analysguiden’s Manager Peter Malmqvist
Spotlight
08-511 68 000
info@spotlightstockmarket.com
Press contact
Jenny Sondal, CMO Spotlight
+46 70 7749303
js@spotlightstockmarket.com
ABOUT SPOTLIGHT
Spotlight is the marketplace where investors and growth companies meet. At Spotlight it is easier and safer for companies to be listed. We offer a overall solution that increase the visibility for our companies through unique media collaborations. Investors get through Spotlight the opportunity to become shareholders in more than 170 growth companies from different businesses and countries, among those are Hamlet Pharma,Freetrailer and Synthetic MR.